Highlights
- Total Revenue (TTM)
- $21.06M
- Gross Profit (TTM)
- $21.06M
- Year Range
- $13.77 - $20.46
Share Price Chart
Loading graphics...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Tekla Healthcare Investors, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Loading graphics...
Returns By Period
Tekla Healthcare Investors (HQH) has returned -3.09% so far this year and 24.44% over the past 12 months. Over the last ten years, HQH has returned 6.57% per year, falling short of the S&P 500 Index benchmark, which averaged 12.16% annually.
Tekla Healthcare Investors
- 1D
- 3.13%
- 1M
- -7.10%
- YTD
- -3.09%
- 6M
- 2.57%
- 1Y
- 24.44%
- 3Y*
- 13.07%
- 5Y*
- 4.30%
- 10Y*
- 6.57%
Benchmark (S&P 500 Index)
- 1D
- 2.91%
- 1M
- -5.09%
- YTD
- -4.63%
- 6M
- -2.39%
- 1Y
- 16.33%
- 3Y*
- 16.69%
- 5Y*
- 10.18%
- 10Y*
- 12.16%
Monthly Returns
Based on dividend-adjusted daily data since Jan 5, 1988, HQH's average daily return is +0.05%, while the average monthly return is +1.09%. At this rate, your investment would double in approximately 5.3 years.
Historically, 56% of months were positive and 44% were negative. The best month was Feb 2000 with a return of +60.4%, while the worst month was Mar 2000 at -30.5%. The longest winning streak lasted 10 consecutive months, and the longest losing streak was 5 months.
On a daily basis, HQH closed higher 48% of trading days. The best single day was Feb 17, 2000 with a return of +13.3%, while the worst single day was Nov 14, 1996 at -22.1%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 0.84% | 3.45% | -7.10% | -3.09% | |||||||||
| 2025 | 13.15% | -2.23% | -5.58% | 0.00% | -3.02% | 1.77% | 1.03% | 9.00% | 11.61% | 6.66% | 2.32% | -3.02% | 34.12% |
| 2024 | 3.38% | 0.97% | 0.24% | -4.21% | 6.15% | 5.43% | 6.36% | 5.27% | -1.74% | -3.17% | 0.18% | -7.92% | 10.22% |
| 2023 | 5.67% | -3.29% | -1.84% | -1.36% | -1.47% | 1.73% | 0.06% | -0.59% | -6.10% | -6.05% | 4.64% | 11.13% | 1.22% |
| 2022 | -5.01% | -9.13% | 3.80% | -2.79% | -0.86% | -4.50% | 3.37% | -1.77% | -7.10% | 8.51% | 4.43% | -6.15% | -17.27% |
| 2021 | 0.04% | 6.81% | -2.20% | 1.84% | 0.67% | 4.93% | 0.89% | 5.00% | -4.41% | 2.15% | -5.42% | -1.82% | 7.99% |
Benchmark Metrics
Tekla Healthcare Investors has an annualized alpha of 5.01%, beta of 0.83, and R² of 0.30 versus S&P 500 Index. Calculated based on daily prices since January 06, 1988.
- This stock participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (97.95%) than losses (92.50%) — typical of diversified or defensive assets.
- R² of 0.30 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 5.01%
- Beta
- 0.83
- R²
- 0.30
- Upside Capture
- 97.95%
- Downside Capture
- 92.50%
Return for Risk
Risk / Return Rank
HQH ranks 72 for risk / return — better than 72% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Tekla Healthcare Investors (HQH) and compare them to a chosen benchmark (S&P 500 Index).
| HQH | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.05 | 0.90 | +0.16 |
Sortino ratioReturn per unit of downside risk | 1.49 | 1.39 | +0.11 |
Omega ratioGain probability vs. loss probability | 1.19 | 1.21 | -0.02 |
Calmar ratioReturn relative to maximum drawdown | 1.73 | 1.40 | +0.33 |
Martin ratioReturn relative to average drawdown | 5.46 | 6.61 | -1.15 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Explore HQH risk-adjusted metrics in detail
Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.
Dividends
Dividend History
Tekla Healthcare Investors provided a 12.65% dividend yield over the last twelve months, with an annual payout of $2.25 per share.
| Period | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $2.25 | $2.19 | $2.28 | $1.60 | $1.71 | $2.04 | $1.90 | $1.72 | $1.93 | $1.98 | $2.07 | $3.55 |
Dividend yield | 12.65% | 11.56% | 14.21% | 9.66% | 9.50% | 8.59% | 7.97% | 8.24% | 10.75% | 8.78% | 9.80% | 11.97% |
Monthly Dividends
The table displays the monthly dividend distributions for Tekla Healthcare Investors. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.63 | $0.00 | $0.63 | |||||||||
| 2025 | $0.00 | $0.57 | $0.00 | $0.00 | $0.54 | $0.00 | $0.00 | $0.51 | $0.00 | $0.00 | $0.57 | $0.00 | $2.19 |
| 2024 | $0.00 | $0.48 | $0.00 | $0.00 | $0.59 | $0.00 | $0.00 | $0.59 | $0.00 | $0.00 | $0.62 | $0.00 | $2.28 |
| 2023 | $0.00 | $0.42 | $0.00 | $0.00 | $0.40 | $0.00 | $0.00 | $0.40 | $0.00 | $0.00 | $0.38 | $0.00 | $1.60 |
| 2022 | $0.00 | $0.48 | $0.00 | $0.00 | $0.44 | $0.00 | $0.00 | $0.40 | $0.00 | $0.00 | $0.39 | $0.00 | $1.71 |
| 2021 | $0.00 | $0.51 | $0.00 | $0.00 | $0.50 | $0.00 | $0.00 | $0.52 | $0.00 | $0.00 | $0.51 | $0.00 | $2.04 |
Dividend Yield & Payout
Dividend Yield
Tekla Healthcare Investors has a dividend yield of 12.65%, which means its dividend payment is significantly above the market average.
Payout Ratio
Tekla Healthcare Investors has a payout ratio of 6.95%, which is below the market average. This means Tekla Healthcare Investors returns a smaller proportion of its earnings to shareholders as dividends, suggesting it retains a higher portion for reinvestment, growth, or debt payment.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading graphics...
Worst Drawdowns
The table below displays the maximum drawdowns of the Tekla Healthcare Investors. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Tekla Healthcare Investors was 62.36%, occurring on Oct 8, 1998. Recovery took 336 trading sessions.
The current Tekla Healthcare Investors drawdown is 10.29%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -62.36% | Jan 10, 1992 | 1706 | Oct 8, 1998 | 336 | Feb 8, 2000 | 2042 |
| -54.64% | Feb 18, 2000 | 662 | Oct 9, 2002 | 1168 | Jun 1, 2007 | 1830 |
| -45.27% | Aug 18, 2008 | 140 | Mar 9, 2009 | 469 | Jan 14, 2011 | 609 |
| -41.83% | Jul 20, 2015 | 144 | Feb 11, 2016 | 1226 | Dec 23, 2020 | 1370 |
| -37.55% | Aug 26, 2021 | 547 | Oct 27, 2023 | 480 | Sep 29, 2025 | 1027 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading graphics...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Tekla Healthcare Investors over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Tekla Healthcare Investors is priced in the market compared to other companies in the Asset Management industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |